"Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2013" Published
Global Markets Direct's, 'Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma). Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, Half Year is built using...
View full press release